Global Hormone Replacement Therapy Market Growth ascribed to the Growing Post-Menopausal Issue Awareness
Inkwood Research estimates that the Global Hormone Replacement Therapy Market is evaluated to grow with a CAGR of 7.67% in terms of revenue during the forecasted period of 2021-2028.
“Browse 53 Market Data Tables and 46 Figures spread over 204
Pages, along with an in-depth TOC on the Global Hormone Replacement Therapy Market Forecast
2021-2028.”
REQUEST FREE SAMPLE LINK - https://www.inkwoodresearch.com/reports/hormone-replacement-therapy-market#request-free-sample
VIEW TABLE OF
CONTENT LINK - https://www.inkwoodresearch.com/reports/hormone-replacement-therapy-market#table-of-content
BUY NOW - https://www.inkwoodresearch.com/reports/hormone-replacement-therapy-market
Hormone replacement therapy (HRT) balances progesterone and
estrogen levels during menopause. It also helps alleviate hot flashes,
sweating, and other menopause symptoms, and minimize osteoporosis risks.
Prevailing
Awareness about Post-Menopausal Issues drives Market Growth
Adequate health education has increased the awareness of
health problems during menopause to 88-98% globally. As per the clinical trials
by the Journal of Education and Health Promotion, structured education and
knowledge helped women develop a positive attitude towards post-menopausal
issues. As a result, proper health education programs about menopause are
increasingly recommended. Moreover, the growing awareness of HRT is observed
among women attending primary healthcare centers in Western Saudi Arabia. Such
factors are projected to boost the market growth.
To know more about this report, request
a free sample copy.
Estrogen Hormone
Replacement Therapy: The Major Therapy Type
Estrogen replacement therapy (ERT) or estrogen hormone
replacement therapy entails estrogen hormones commonly used to treat menopause
symptoms and lessen the post-menopausal symptoms like night sweats, hot
flashes, itching, burning, discomfort during sexual intercourse, and vaginal
dryness. Estrogen is available in several forms. These include skin patches,
gels, creams, sprays, and pills.
There have been significant developments in ERT. Innovative
drug delivery systems like vaginal estrogen products and transdermal estrogen
patches facilitate safe treatment options. Also, the US FDA (Food and Drug
Administration) approval for many estrogen hormone products propels the ERT
segment growth. Femoston (estradiol and dydrogesterone), Diane-35 (cyproterone
acetate and ethinyl estradiol) (Bayer AG), Vivelle-Dot (estradiol transdermal
system) (Novartis International AG), etc., are among the commercially available
products in the market.
Asia-Pacific:
The Fastest-Growing Region
The Asia-Pacific houses a surging elderly population. This
is one of the dominant factors propelling the market growth. The increasing
need for hormone replacement therapy in the region is accredited to rising
awareness among end-users and enhanced healthcare infrastructure in accordance
with menopausal and hormonal disorders. Novel formulations, reimbursement
policies, and rising awareness on post-menopausal stress and complications, are
among important growth drivers.
The intense competitive rivalry is attributed to aggressive
marketing campaigns by players. ANI Pharmaceuticals, Genentech Inc, Ipsen, Amgen,
Bayer AG, etc.
About Inkwood Research
Inkwood Research specializes in syndicated & customized
research reports and consulting services. Market intelligence studies with
relevant fact-based research are customized across industry verticals such as
technology, automotive, chemicals, materials, healthcare, and energy, with an
objective comprehension that acknowledges the business environments. Our
geographical analysis comprises North & South America, CEE, CIS, Middle
East, Europe, Asia, and Africa.
Contact Us
https://www.inkwoodresearch.com
1-(857)293-0150
Related Reports:
GLOBAL
CYSTIC FIBROSIS THERAPEUTICS MARKET
GLOBAL
NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET
GLOBAL
DERMATOLOGICAL THERAPEUTICS MARKET
Comments
Post a Comment